Heart Failure Resilience Intervention for Caregivers

NCT ID: NCT03963583

Last Updated: 2025-11-24

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 33 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-04-01
• Study Completion Date: 2024-10-31

Brief Summary

Heart failure (HF) patients with supportive caregivers have better physical health, emotional health, and quality of life. But caregivers have an increased risk of caregivers' own worsening health and often feel a sense of burden related to caregiving. However, caregivers receive very little support to balance caring for the patient with caring for themselves. Therefore, this research will provide a program for caregivers of advanced heart failure patients to build on the caregiver's strengths, sense of purpose, and set goals for healthy lifestyle changes. The investigators believe that caregivers who receive the program will have better quality of life, less sense of burden, and a healthier lifestyle.

Detailed Description

Aim 1) Develop the intervention through focus groups and human-centered design with key stakeholders with particular focus on race, gender and financial strain. Key stakeholders including patients, caregivers and healthcare providers will discuss prototypes and refine intervention components through human-centered design.

Aim 2) Refine intervention components through an open label pilot (N=5) of the intervention, followed by in-depth interviews. We will assess the salient features of the novel intervention components using mixed methods including examination of all quantitative measures and qualitative interviews to explore acceptability, participant/interventionist interactions, home environment factors, goal achievement and perceived value of intervention. Intervention components will be adapted for the trial based on results of aims 1 and 2.

Aim 3) Conduct a single-masked, waitlist control pilot trial of the HEROIC intervention (N=36). We hypothesize that caregivers who receive the intervention will show greater improvement in primary outcomes (preventive health behaviors, caregiver burden and QOL) and potential mechanisms (self-efficacy and biomarkers of resilience [interleukins 6 and 10]) than control caregivers.

Randomization: Caregivers will be randomized using a computer algorithm via REDCap to receive either: (1) intervention or (2) waitlist. Random assignment will be stratified by spousal vs non-spousal caregivers due to increased burden among non-spousal caregivers.

Waitlisted Control Group: The waitlisted group will receive usual care for caregivers for the first 16 weeks, which is normally limited to inclusion in some clinical assessment and teaching during patient visits. Waitlisted participants will receive monthly study postcards to encourage retention. After 16 weeks, they will begin the intervention.

Setting:

Aim 1: Key Stakeholder meetings will be held at the Johns Hopkins University School of Nursing, which is located within walking distance of the Heart Failure Bridge Clinic and supported by the Community Research Advisory Council.

Aims 2-3: Study visits will be conducted in the home of the caregiver.

Intervention Components

The intervention will be guided by the theory and evidence-based practices that have been successful in previous work. For the proposed study, every participant will receive each component of the intervention but interventionists will tailor content to each participant's goals. The investigators will focus on overall preventive health behaviors broadly categorized as physical activity, stress management, rest, healthy diet and appropriate healthcare utilization. As part of the intervention, the nurse and the caregiver will discuss preventive health categories. In this conversation, the caregiver will prioritize the preventive health categories that they would most like to address and then set goals towards them. Allowing the caregiver maximum control over this goal-setting, without placing additional burden on the caregiver is one aspect of increasing self-efficacy and person-centeredness. Because the intervention will allow participants to pick their own health goals, the investigators will measure goal attainment related to preventive health behaviors, rather than a standardized survey of predetermined preventive health behaviors.

Intervention Delivery/Study Visits

The intervention delivery characteristics will consist of an assessment-driven, tailored package of interventions delivered by a nurse interventionist. Nurse interventionists will be trained and equipped with education materials vetted by national organizations leading preventive health research such as the American Heart Association (Healthy for Good) and National Institute of Aging (Go4Life). The investigators propose an intervention incorporating 3 individualized, nurse-led, home-based sessions, with telephone check-ins and text reminders, according to participant preference. Baseline, 16 and 32-week data will be collected by interviewers masked to treatment assignment and without interventionist contact.

Interventional Protocol

The nurse will meet with the caregiver to perform the initial assessment in which the nurse will focus on preventive health behaviors and factors contributing to a sense of burden. To build rapport and model the importance of physical activity, the nurse will allow the caregiver to choose a short physical activity (ie. Walk around the block, 2 minutes of dancing etc). In this assessment, the nurse and the caregiver identify and prioritize goals, and make plans to achieve those goals. The nurse will provide the HEROIC Handbook, which will be developed following aim 1 and include evidence-based educational materials, contact information, and a calendar of sessions that the participant keeps for reference. In each session, the nurse assesses goal attainment, reinforces strategy use, reviews problem-solving, refines strategies (such as Go4Life physical activities and Healthy for Good materials), and provides education and resources to address future needs. Following the session, the nurse will find additional resources, tailored to each caregiver. In the final session, the nurse reviews the participants' strategies and helps to generalize them to other possible challenges or goals. Sessions will be spaced to encourage practicing new strategies independently after developing them together with the nurse. Although this intervention structure has been successful in work by the mentorship team, the investigators will adjust the timing and frequency of study visits based on feedback in phases 1 and 2. Bi-monthly meetings of the nurse with the site Research Coordinator and the principal investigator will ensure smooth communication, address challenges, supervision, and adherence to intervention fidelity.

Conditions

Heart Failure; Caregivers

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

HEROIC Intervention Group

This group will receive the HEROIC intervention.

Group Type: EXPERIMENTAL

HEROIC

Intervention Type: BEHAVIORAL

The HEROIC intervention will include individualized, nurse-led sessions focused on;

1. a whole-person assessment including preventive health behaviors, personal goals, and purpose in life

2. discussion of caregiving in the context of the caregiver's identified 'purpose' which supports meaning-making and provides rationale for goal-setting

3. co-development of a plan to address caregiver goals to improve preventive health behaviors and/or reduce caregiver burden

4. 'walking meetings' to model the importance of exercise while discussing incremental action plans to help caregivers achieve goals.

Waitlist Control Group

The waitlisted group will receive usual care for caregivers for the first 12 weeks, which is normally limited to inclusion in some clinical assessment and teaching during patient visits. Waitlisted participants will receive monthly study postcards to encourage retention. After 12 weeks, they will begin the intervention.

Group Type: EXPERIMENTAL

HEROIC

Intervention Type: BEHAVIORAL

The HEROIC intervention will include individualized, nurse-led sessions focused on;

1. a whole-person assessment including preventive health behaviors, personal goals, and purpose in life

2. discussion of caregiving in the context of the caregiver's identified 'purpose' which supports meaning-making and provides rationale for goal-setting

3. co-development of a plan to address caregiver goals to improve preventive health behaviors and/or reduce caregiver burden

4. 'walking meetings' to model the importance of exercise while discussing incremental action plans to help caregivers achieve goals.

Interventions

HEROIC

The HEROIC intervention will include individualized, nurse-led sessions focused on;

1. a whole-person assessment including preventive health behaviors, personal goals, and purpose in life

2. discussion of caregiving in the context of the caregiver's identified 'purpose' which supports meaning-making and provides rationale for goal-setting

3. co-development of a plan to address caregiver goals to improve preventive health behaviors and/or reduce caregiver burden

4. 'walking meetings' to model the importance of exercise while discussing incremental action plans to help caregivers achieve goals.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

Aim 2 & 3 Inclusion:

• Caregivers of patients served by the HF Bridge Clinic will be included if

1. the patient was hospitalized within 6 months

2. the caregiver agrees to work on goals that increase preventive health behaviors and/or decrease burden

3. caregivers live with the patient or visit them to provide care more than 3 times per week

4. the caregiver is 50 years or older and e) the caregiver is the spouse/partner or child of the patient.

Exclusion Criteria

• Caregivers who

1. themselves have a terminal diagnosis

2. or are cognitively impaired based on Mini-Mental State Examination (MMSE) screening will be excluded as response to the intervention may vary in these groups.

• Minimum Eligible Age: 50 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role: collaborator

Johns Hopkins University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Martha Abshire Saylor, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University School of Nursing

Locations

Johns Hopkins School of Nursing

Baltimore, Maryland, United States

Countries

United States

Provided Documents

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

1K12HD085845

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB00277814

Identifier Type: -

Identifier Source: org_study_id